Davy Research

Amryt Pharma

Signs distribution agreement
Pharma and healthcare
Amryt Pharma

DAVY VIEW

Amryt has signed an exclusive distribution agreement with El Seif, a Saudi Arabian distributor of medical devices and pharmaceuticals. The agreement covers its commercial product Lojuxta and its late stage clinical drug AP101. This is an important milestone for Amryt as it establishes a presence in the key commercial territory of Saudi Arabia and is indicative of the company’s broader strategy to extend its footprint across key territories.

Download full report with analyst certification and important disclosures
Download
Download full report with analyst certification and important disclosures
Download
  • RATINGS AND PRICE CORRECT AT TIME OF ISSUE


  • Amryt Pharma

    Closing Price: 1913p

  • RATING 14/09/17

  • PREVIOUS RATING N/A

Analyst(S)

COMPANY DATA

JUMP TO